GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Return-on-Tangible-Equity

Aptamer Group (LSE:APTA) Return-on-Tangible-Equity : -340.14% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Aptamer Group's annualized net income for the quarter that ended in Dec. 2023 was £-3.61 Mil. Aptamer Group's average shareholder tangible equity for the quarter that ended in Dec. 2023 was £1.06 Mil. Therefore, Aptamer Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was -340.14%.

The historical rank and industry rank for Aptamer Group's Return-on-Tangible-Equity or its related term are showing as below:

LSE:APTA' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -289.19   Med: -87.13   Max: -51.47
Current: -289.19

During the past 4 years, Aptamer Group's highest Return-on-Tangible-Equity was -51.47%. The lowest was -289.19%. And the median was -87.13%.

LSE:APTA's Return-on-Tangible-Equity is ranked worse than
91.05% of 1296 companies
in the Biotechnology industry
Industry Median: -46.86 vs LSE:APTA: -289.19

Aptamer Group Return-on-Tangible-Equity Historical Data

The historical data trend for Aptamer Group's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Return-on-Tangible-Equity Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23
Return-on-Tangible-Equity
-51.47 -121.51 -52.74 -197.28

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial -49.88 -24.36 -81.88 -386.77 -340.14

Competitive Comparison of Aptamer Group's Return-on-Tangible-Equity

For the Biotechnology subindustry, Aptamer Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptamer Group's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Return-on-Tangible-Equity falls into.



Aptamer Group Return-on-Tangible-Equity Calculation

Aptamer Group's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jun. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=-7.836/( (7.71+0.234 )/ 2 )
=-7.836/3.972
=-197.28 %

Aptamer Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-3.614/( (0.234+1.891)/ 2 )
=-3.614/1.0625
=-340.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Aptamer Group  (LSE:APTA) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Aptamer Group Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Group (LSE:APTA) Business Description

Traded in Other Exchanges
N/A
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines